Lack of clinically significant drug interactions between nevirapine and buprenorphine
Saved in:
McCance-Katz, E.F., ET AL., Lack of clinically significant drug interactions between nevirapine and buprenorphine. American Journal on Addictions, Vol. 19, no. 1 (2010), p. 30-37.
Ref.
185666
Location:
SIIS R.1264 Archivo
Palabras clave:
Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades infecciosas, Estudio epidemiológico, Fármacos, Interacción, Programas de mantenimiento, Sida, Tratamiento, EE.UU.
Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades infecciosas, Estudio epidemiológico, Fármacos, Interacción, Programas de mantenimiento, Sida, Tratamiento, EE.UU.
Similar Items: Lack of clinically significant drug interactions between nevirapine and buprenorphine
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
- Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir
- INTERACTION BETWEEN BUPRENORPHINE AND ATAZANAVIR OR ATAZANAVIR RITONAVIR
- Effect of cocaine use on buprenorphine pharmacokinetics in humans
- Benzodiazepines, methadone and buprenorphine: interactions and clinical management
- Drug interactions between antiretroviral medications and medications used in the treatment of drug addiction: research needs